Nuo Therapeutics, Inc.
AURX
$1.74
$0.2113.73%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.21% | 14.10% | -7.05% | 23.80% | -8.51% |
| Total Depreciation and Amortization | 14.79% | 38.54% | 3.02% | -27.64% | 1.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.39% | -182.71% | 1,541.94% | -84.95% | -67.35% |
| Change in Net Operating Assets | 3,288.94% | 3.11% | 111.09% | -277.29% | 190.67% |
| Cash from Operations | 100.37% | -0.62% | 29.47% | -22.90% | 16.23% |
| Capital Expenditure | -- | 100.00% | -3,580.49% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -3,580.49% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -89.35% | 5.86% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -89.35% | 5.86% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.99% | -289.80% | 97.38% | 118.99% | -293.20% |